On September 8, 2022, Wilson Sonsini was named “Hatch-Waxman Litigation Firm of the Year – Generic” at the 2022 LMG Life Sciences Awards. The firm was also recognized under “Hatch-Waxman Impact Cases of the Year” for its work on Celgene v. Mylan (Federal Circuit, 2021), “Patent Impact Cases of the Year” for its work on ModernaTx v. Arbutus (Federal Circuit, 2021), and “Impact Deals of the Year – United States” for its role in Sanofi’s $6.15 billion collaboration with IGM Biosciences. Additionally, Wilson Sonsini partner Michael Rosato was named “Post-Grant Proceedings Attorney of the Year.” Now in its 10thyear, LMG's annual awards program honors the top firms and legal professionals in the life sciences market. Awards are based on interviews and surveys completed by active industry participants.
Wilson Sonsini was also named a finalist in the following categories: Corporate Firm of the Year, Venture Capital Firm of the Year, and Intellectual Property Firm of the Year. In addition to these firm awards, three Wilson Sonsini partners were named as finalists for individual awards: Jennifer Fang for U.S. Rising Star: Financial and Corporate; T.O. Kong for Appellate Litigator of the Year: Intellectual Property; and Vern Norviel for Patent Strategy Attorney of the Year: California.
Click here to view to the full list of winners and finalists.